Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019
Article By:
ChinaBio® Today
Saturday, December 29, 2018 4:08 PM EDT
Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.
Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal With Zymeworks
Article By:
ChinaBio® Today
Saturday, December 1, 2018 4:44 PM EDT
BeiGene of Beijing announced cancer drug deals worth up to $1.3 billion with Vancouver's Zymeworks. BeiGene will acquire Asian rights to two bispecific antibodies from Zymeworks and will have rights to three to-be-discovered bispecific candidates.
Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates
Article By:
ChinaBio® Today
Saturday, November 24, 2018 4:09 PM EDT
Alphamab Oncology, a clinical-stage Suzhou biopharma, completed a Series A funding with over $100 million in capital. Earlier this year, Alphamab Oncology was spun out of Suzhou Alphamab with seven oncology assets and related technology platforms.
Stocks For You To Swing-Trade: LLY CMA TTWO
These look like some good picks. Liking $CMA, $LLY, $TTWO